Amarin Corp Plcuk (AMRN) Treasury Shares (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Treasury Shares of $69.3 million for Q2 2026, up 3.26% year-over-year from $67.1 million in Q2 2025, and little changed quarter-over-quarter from $69.0 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Treasury Shares (2010 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Treasury Shares for 17 consecutive years, with $69.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Treasury Shares rose 3.26% year-over-year to $69.3 million; the TTM figure through Jun 2026 stood at $69.3 million (up 3.26% YoY), while the FY2025 annual figure was $67.4 million, up 3.11% from the prior year.
- Treasury Shares steadied at $69.3 million in Q2 2026 per AMRN's latest filing, from $69.0 million in the prior quarter.
- Across five years, Treasury Shares topped out at $16.2 million in Q2 2026 and bottomed at -$16.0 million in Q1 2026.
- Historically, Treasury Shares has averaged -$6.0 million across 5 years, with a median of -$9.1 million in 2023.
- On a YoY basis, Treasury Shares climbed as much as 5.02% in 2022 and fell as far as 1.72% in 2022.
- Amarin Corp Plc\Uk's Treasury Shares stood at $61.8 million in 2022, then advanced by 3.21% to $63.8 million in 2023, then increased by 2.47% to $65.3 million in 2024, then grew by 3.11% to $67.4 million in 2025, then gained by 2.87% to $69.3 million in 2026.
- Business Quant data shows AMRN's Treasury Shares at $69.3 million in Q2 2026, $69.0 million in Q1 2026, and $67.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 75.86 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 77.11 Mn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 1.11 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 49.00 Mn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 115.19 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn | 69.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.20 Mn |
| Jun 30, 2026 | 16.20 Mn |
| Jun 30, 2026 | 69.29 Mn |
| Jun 30, 2026 | 69.29 Mn |
| Mar 31, 2026 | 69.05 Mn |
| Mar 31, 2026 | -15.95 Mn |
| Mar 31, 2026 | 69.05 Mn |
| Mar 31, 2026 | -15.95 Mn |
| Dec 31, 2025 | 13.63 Mn |
| Dec 31, 2025 | 67.36 Mn |
| Dec 31, 2025 | 67.36 Mn |
| Dec 31, 2025 | 13.63 Mn |
| Sep 30, 2025 | 67.36 Mn |
| Sep 30, 2025 | 13.63 Mn |
| Sep 30, 2025 | 13.63 Mn |
| Sep 30, 2025 | 67.36 Mn |
| Jun 30, 2025 | -13.31 Mn |
| Jun 30, 2025 | 67.11 Mn |
| Jun 30, 2025 | 67.11 Mn |
| Jun 30, 2025 | -13.31 Mn |